Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
CAMBRIDGE, MA—Bala Mohan, the Senior Vice President and Chief Improvement Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), just lately executed a sequence of inventory transactions, in keeping with a submitting with the Securities and Trade Fee. On January 14, Mohan offered…
Timothy B. Lowinger, the Senior Vice President and Chief Science & Expertise Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), not too long ago reported a sale of firm inventory. In response to the SEC submitting, Lowinger offered 3,483 shares of frequent…
CAMBRIDGE, MA—Brian DeSchuytner, Senior Vice President, Chief Working Officer, and Chief Monetary Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), just lately executed a sale of firm inventory, based on a current SEC submitting. The transaction comes as the corporate’s inventory trades…
On yesterday, January 13, 2025, Ashish acquired 2,646 shares of frequent inventory via the vesting of RSUs, with no money exchanged on this transaction. Following these transactions, Ashish holds a complete of 49,396 shares of Mersana Therapeutics (NASDAQ:MRSN) frequent inventory.…
The sale was performed to cowl tax withholding obligations associated to the vesting and settlement of restricted inventory models (RSUs). These RSUs had been initially awarded to Protopapas, who beforehand served as the corporate’s President and CEO. As a part…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a $454 million market cap biotech firm, not too long ago reported that its Chief Govt Officer, Jon Congleton, bought 18,333 shares of widespread inventory. The transactions occurred on January 13, 2025, at a weighted common…
Adam Scott Levy, the Chief Monetary Officer and Secretary of Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a clinical-stage biotech firm with a market capitalization of $454 million, lately executed a sequence of inventory gross sales in response to a submitting with the…
KUALA LUMPUR—Suria Sukses Engineering Sdn Bhd, a major shareholder of Graphjet Expertise (NASDAQ:GTI), has just lately offered a considerable portion of its holdings within the firm. The sale comes as GTI’s inventory trades close to $0.45, down almost 50% year-to-date…
Thomas Pike, Chief Govt Officer of Fortrea Holdings Inc. (NASDAQ:FTRE), has bought a portion of his holdings within the firm. In accordance with a latest SEC submitting, Pike bought 11,268 shares of frequent inventory on January 13, 2025, at a…
Samantha Giuggio, Chief Dealer Officer at Fathom Holdings Inc. (NASDAQ:FTHM), not too long ago reported the sale of firm inventory valued at roughly $1,260. The transactions occurred on January 2 and January 10, 2025, amid a difficult interval for the…
